Medicare 2022 Part C & D Star Ratings Technical Notes. Centers for Medicare and Medicaid Services. https://www.cms.gov/files/document/2022technotespreview120210804a.pdf Accessed January2, 2022.
2.
FarleyJF, UrickBY. Is it time to replace the star ratings adherence measures?. J Manag Care Spec Pharm, 2021; 27:399–404.
3.
2021 National Impact Assessment of the Centers for Medicare & Medicaid Services (CMS) Quality Measures Report. Centers for Medicare and Medicaid Services. https://www.cms.gov/files/document/2021-national-impact-assessment-report.pdf Accessed January2, 2022.
4.
ParekhN, MunshiKD, HernandezI, GelladWF, HendersonR, ShrankWH. Impact of star rating medication adherence measures on adherence for targeted and nontargeted medications. Value Health, 2019; 22(11):1266–1274.
5.
Frier LevittL. PBM DIR Fees Costing Medicare and Beneficiaries: Investigative White Paper on Background, Cost Impact, and Legal Issues. 2022. https://communityoncology.org/wp-content/uploads/2017/01/COA_White_Paper_on_DIR-Final.pdf Accessed December9, 2022.
6.
FrancoJVA, TerrasaSA, KopitowskiKS. Medication discrepancies and potentially inadequate prescriptions in elderly adults with polypharmacy in ambulatory care. J Family Med Prim Care, 2017; 6:78–82.
7.
GlassbergMB, TrygstadT, WeiD, RobinsonT, FarleyJF. Accuracy of prescription claims data in identifying truly nonadherent patients. J Manag Care Spec Pharm, 2019; 25(12):1349–1356.
8.
StuartBC, DaiM, XuJ, LohFH, DoughertyJS. Does good medication adherence really save payers money?. Med Care, 2015; 53:517–523.
9.
StroupeKT, NaziK, HoganTP, et al.Web-based patient portal use and medication overlap from VA and private-sector pharmacies among older veterans. J Manag Care Spec Pharm, 2021; 27:983–994.
10.
Prieto-MerinoD, MulickA, ArmstrongC, et al.Estimating proportion of days covered (PDC) using real-world online medicine suppliers' datasets. J Pharm Policy Pract, 2021; 14:113.
11.
LesterCA, LookKA, ChuiMA. Is the currently used prescription adjudication date a good proxy for calculating medication refill adherence?. J Manag Care Spec Pharm, 2016; 22(11):1311–1317.
12.
AbbassI, RevereL, MitchellJ, AppariA. Medication nonadherence: The role of cost, community, and individual factors. Health Serv Res, 2017; 52:1511–1533.
13.
ChoudhryNK, FischerMA, SmithBF, et al.Five features of value-based insurance design plans were associated with higher rates of medication adherence. Health Aff (Millwood), 2014; 33:493–501.
14.
ParkY, RazaS, GeorgeA, AgrawalR, KoJ. The effect of formulary restrictions on patient and payer outcomes: A systematic literature review. J Manag Care Spec Pharm, 2017; 23:893–901.
